Document › Details
PerkinElmer, Inc.. (11/20/12). "Press Release: PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence and Business in the Fast Developing Region". Waltham, MA.
|Organisation||PerkinElmer (ZA, Midrand)|
|Organisation 2||Life and Analytical Science (Pty) Ltd. (LAS)|
|Group||Separation Scientific (Group)|
|Product||laboratory equipment and instruments|
|Product 2||diagnostics (medical/biological)|
|Person||Clark, Louis (PerkinElmer 201211 General Manager South Africa)|
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct operations in Midrand, South Africa. The new PerkinElmer Southern African headquarters will support the Company's business across all Southern African countries in the following key markets: academia, mining and mineral testing, chemical and petrochemical analysis, pharmaceutical applications, and food and beverage safety testing.
"Southern Africa represents a critical region for PerkinElmer and is an integral component of our growth and geographic expansion strategy," said Lapo Paladini, chief marketing officer, PerkinElmer. "The opening of our new headquarters will bring our knowledge and expertise as well as our innovative solutions directly to Southern Africa in order to support the fast growing local economy while helping customers advance human and environmental health in the region."
The new Southern Africa headquarters will be equipped with a Customer Knowledge Center which will serve as a demonstration, application support and service center.
"We are excited about this important investment in Southern Africa. The new headquarters will have responsibility for our analytical sciences and laboratory services offerings, including providing customers with a direct application support, sales and service channel," said Louis Clark, Southern Africa, general manager, PerkinElmer. "We would like to take this opportunity to thank Life & Analytical Sciences (LAS) for their dedication and efforts in supporting our analytical sciences and laboratory services customers over the last eight years. We look forward to working closely with their parent company, Separation Scientific (SepSci), as they continue to represent and support our diagnostics and life sciences businesses and customers."
Located in Midrand, a commercial hub strategically situated between Johannesburg and Pretoria, the facility will initially serve South Africa and neighboring countries and will be supported by 25 sales, support and service employees.
Customers may contact the new Southern Africa headquarters at firstname.lastname@example.org, +27 11 564 2400 and http://www.perkinelmer.com.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) our ability to realize the full value of our intangible assets; (21) significant fluctuations in our stock price; (22) reduction or elimination of dividends on our common stock; and (23) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
# # #
Edelman (On behalf of PerkinElmer, Inc.)
Vice President, Corporate Communications
Phone: 781- 663-5701
Record changed: 2016-03-20
More documents for PerkinElmer (Group)
-  PerkinElmer, Inc.. (12/22/16). "Press Release: PerkinElmer to Sell Medical Imaging Business to Varian Medical Systems". Waltham, MA....
-  PerkinElmer, Inc.. (12/14/16). "Press Release: PerkinElmer to Present at J.P. Morgan 35th Annual Healthcare Conference". Waltham, MA....
-  PerkinElmer, Inc.. (11/21/16). "Press Release: PerkinElmer to Present at Citi Global Healthcare Conference". Waltham, MA....
-  PerkinElmer, Inc.. (11/14/16). "Press Release: PerkinElmer to Present at Piper Jaffray Healthcare Conference". Waltham, MA....
-  PerkinElmer, Inc.. (11/7/16). "Press Release: PerkinElmer Announces Financial Results for the Third Quarter of 2016". Waltham, MA....
-  PerkinElmer, Inc.. (10/26/16). "Press Release: PerkinElmer Board Declares Quarterly Dividend". Waltham, MA....
-  PerkinElmer, Inc.. (10/17/16). "Press Release: PerkinElmer Elects Samuel Chapin to Board of Directors". Waltham, MA....
-  PerkinElmer, Inc.. (10/10/16). "Press Release: PerkinElmer's New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs". Waltham, MA & Shanghai....
-  PerkinElmer, Inc.. (9/26/16). "Press Release: PerkinElmer Announces New Organizational Structure". Waltham, MA....
-  PerkinElmer, Inc.. (9/1/16). "Press Release: PerkinElmer to Present at Morgan Stanley Global Healthcare Conference". Waltham, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]